Načítá se...
Association of Non-LDL Indices with Recurrent Stroke Risk while on Lipid-Modifying Therapy
Aims: Low-density lipoprotein (LDL)-lowering statin therapy is an established secondary stroke prevention strategy. However, the differential impact of key non-LDL levels on recurrent stroke risk, while on lipid-modifying therapy (LT), remains unclear. Methods: We analyzed the dataset of a multicent...
Uloženo v:
| Vydáno v: | J Atheroscler Thromb |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Japan Atherosclerosis Society
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7049477/ https://ncbi.nlm.nih.gov/pubmed/31189759 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.49304 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|